770
Views
43
CrossRef citations to date
0
Altmetric
Original Article

Cryoprotectant choice and analyses of freeze-drying drug suspension of nanoparticles with functional stabilisers

, , , , , & show all
Pages 241-248 | Received 03 Dec 2017, Accepted 04 Apr 2018, Published online: 19 Apr 2018

References

  • Bildstein, L., et al., 2009. Freeze-drying of squalenoylated nucleoside analogue nanoparticles. International journal of pharmaceutics, 381, 140–145.
  • Bozdag, S., et al., 2005. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles. Journal of pharmacy and pharmacology, 57, 699–707.
  • Chan, H.-K. and Kwok, P.C.L., 2011. Production methods for nanodrug particles using the bottom-up approach. Advanced drug delivery reviews, 63, 406–416.
  • Chung, N.O., Lee, M.K., and Lee, J., 2012. Mechanism of freeze-drying drug nanosuspensions. International journal of pharmaceutics, 437, 42–50.
  • Dinesh Kumar, V., Verma, P.R.P., and Singh, S.K., 2015. Development and evaluation of biodegradable polymeric nanoparticles for the effective delivery of quercetin using a quality by design approach. LWT food science technology, 61, 330–338.
  • Doktorovova, S., et al., 2013. Trehalose is not a universal solution for solid lipid nanoparticles freeze-drying. Pharmaceutical development and technology, 19, 922–929.
  • Donoso, M.D., Haskell, R.J., and Schartman, R.R., 2012. Surfactant choice and the physical stability of nanosuspension as a function of pH. International journal of pharmaceutics, 439, 1–7.
  • Du, J., et al., 2015. Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies. International journal of pharmaceutics, 495, 738–749.
  • Du, J., et al., 2016. Effect of PEGylated chitosan as multifunctional stabilizer for deacetyl mycoepoxydience nanosuspension design and stability evaluation. Carbohydrate polymers, 153, 471–481.
  • Fonte, P., Reis, S., and Sarmento, B., 2016. Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery. Journal of controlled release, 225, 75–86.
  • Gill, K.K., Kaddoumi, A., and Nazzal, S., 2012. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines. European journal of pharmaceutical science, 46, 64–71.
  • Hao, J., et al., 2016. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspension intended for direct nose-to-brain delivery. Colloid surface B, 147, 376–386.
  • Hatahet, T., et al., 2016. Dermal quercetin smartCrystals(R): Formulation development, antioxidant activity and cellular safety. European journal of pharmaceutics and biopharmaceutics, 102, 51–63.
  • Hirsjärvi, S., et al., 2006. Freeze-drying of low molecular weight poly(L-lactic acid) nanoparticles: effect of cryo- and lyoprotectants. Journal of nanoscience and nanotechnology, 6, 3110–3117.
  • Lai, F., et al., 2013. Nanosuspension improves tretinoin photostability and delivery to the skin. International journal of pharmaceutics, 458, 104–109.
  • Lee, M.K., et al., 2009. Cryoprotectants for freeze drying of drug nano-suspensions: Effect of freezing rate. Journal of pharmaceutical sciences, 98, 4808–4817.
  • Li, Y., et al., 2015. Preparation and characterization of micronized ellagic acid using antisolvent precipitation for oral delivery. International journal of pharmaceutics, 486, 207–216.
  • Moschwitzer, J.P., 2013. Drug nanocrystals in the commercial pharmaceutical development process. International journal of pharmaceutics, 453, 142–156.
  • Muller, R.H., Gohla, S., and Keck, C.M., 2011. State of the art of nanocrystals–special features, production, nanotoxicology aspects and intracellular delivery. European journal of pharmaceutics and biopharmaceutics, 78, 1–9.
  • Shao, Y., Yang, L., and Han, H.K., 2015. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10. European journal of pharmaceutics and biopharmaceutics, 89, 339–346.
  • Wang, L., et al., 2017. Safety of nanosuspensions in drug delivery. Nanomedicine: nanotechnology, biology, and medicine, 13, 455–469.
  • Wang, L., Li, M., and Zhang, N., 2012. Folate-targeted docetaxel-lipid-based-nanosuspension for active-targeted cancer therapy. International journal of nanomedicine, 7, 3281–3294.
  • Wang, Y., et al., 2013. Stability of nanosuspensions in drug delivery. Journal of controlled release, 172, 1126–1141.
  • Wu, L., Zhang, J., and Watanabe, W., 2011. Physical and chemical stability of drug nanoparticles. Advanced drug delivery reviews, 63, 456–469.
  • Yadav, D. and Kumar, N., 2014. Nanonization of curcumin by antisolvent precipitation: process development, characterization, freeze drying and stability performance. International journal of pharmaceutics, 477, 564–577.
  • Zhu, X., et al., 2016. The effects of quercetin-loaded PLGA-TPGS nanoparticles on ultraviolet B-induced skin damages in vivo. Nanomedicine: nanotechnology, 12, 623–632.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.